Ogsiveo approved in EU for treatment of desmoid tumors
Merck’s therapy becomes first authorised option for aggressive soft tissue tumours Merck’s therapy becomes first authorised option for aggressive soft tissue tumours
Previous Post
How Self-Triage and Care Navigation Can Fix Healthcare’s Hidden Problem
Next Post
Long-Term Cilta-Cel Follow-Up Shows Curative Potential in Pretreated Multiple Myeloma
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago